Group One Trading’s Vera Therapeutics VERA Stock Holding History

Group One Trading’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60.1K	Buy	1,400 +200	+17%	+$7.45K	﹤0.01%	5256
2026 Q1	$48.3K	Buy	+1,200	New	+$51.7K	﹤0.01%	5283
2025 Q4	–	Sell	-2,000	Closed	-$58.1K	–	9234
2025 Q3	$58.1K	Sell	2,000 -86,800	-98%	-$2.01M	﹤0.01%	5827
2025 Q2	$2.09M	Buy	88,800 +84,500	+1,965%	+$1.9M	﹤0.01%	2090
2025 Q1	$103K	Sell	4,300 -10,100	-70%	-$325K	﹤0.01%	4580
2024 Q4	$609K	Sell	14,400 -19,300	-57%	-$855K	﹤0.01%	3009
2024 Q3	$1.49M	Buy	33,700 +3,100	+10%	+$118K	﹤0.01%	1972
2024 Q2	$1.11M	Sell	30,600 -17,800	-37%	-$706K	﹤0.01%	1906
2024 Q1	$2.09M	Buy	+48,400	New	+$1.72M	0.01%	1448
2023 Q3	–	Sell	-4,300	Closed	-$69K	–	8363
2023 Q2	$69K	Buy	+4,300	New	+$38.8K	﹤0.01%	4981

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Group One Trading's VERA Position: Q2 2026 in Review

Group One Trading opened a new position in Vera Therapeutics (VERA) in Q2 2026: 68,098 shares worth $2.92M. The stake represents ﹤0.01% of the portfolio and ranks #1861 among its holdings. This is a return to the name: Group One Trading previously reported a position in VERA as recently as Q2 2025.

Group One Trading first reported a position in VERA in Q2 2024 and has held it in 4 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Group One Trading held 68,098 shares of Vera Therapeutics worth $2.92M as of Q2 2026.
Vera Therapeutics was a new Group One Trading position in Q2 2026.
Vera Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #1861 holding.
Group One Trading first reported a position in Vera Therapeutics in Q2 2024 and has held it in 4 quarters since.
219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.